Table 1.
Overall rate of reactogenicity to the ChAdOx1 (AZD1222) COVID-19 vaccine.
| Frequency | Percentage | |
|---|---|---|
| Any adverse event | 553 | 34.7 |
| Pain at the site of injection | 485 | 30.5 |
| Musculoskeletal (joint pain, myalgia) | 438 | 27.5 |
| Skin rash | 307 | 19.3 |
| Gastrointestinal (abdominal pain, diarrhea, vomiting) | 379 | 23.8 |
| Fever | 498 | 31.3 |
| Cardiac disorder (palpitation, chest pain) | 7 | 0.4 |
| Central nervous system | 3 | 0.2 |
| Blood disorder (anemia, bleeding, thrombosis) | 1 | 0.1 |
| Respiratory (shortness of breath) | 2 | 0.1 |
| Hemodynamic vasovagal attack | 2 | 0.1 |
| Lymphadenopathy | 0 | 0 |
| Admission to hospital | 0 | 0 |